Viewing Study NCT00098995


Ignite Creation Date: 2025-12-24 @ 1:50 PM
Ignite Modification Date: 2026-04-08 @ 3:11 PM
Study NCT ID: NCT00098995
Status: COMPLETED
Last Update Posted: 2013-06-26
First Post: 2004-12-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Organization Data

Organization:
Class: NIH
Study ID: PMCC-2004/354
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View